Identification, evaluation, and management of children with autism spectrum disorder
SL Hyman, SE Levy, SM Myers, DZ Kuo, S Apkon… - …, 2020 - publications.aap.org
Autism spectrum disorder (ASD) is a common neurodevelopmental disorder with reported
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …
prevalence in the United States of 1 in 59 children (approximately 1.7%). Core deficits are …
Genetic testing in neurodevelopmental disorders
Neurodevelopmental disorders are the most prevalent chronic medical conditions
encountered in pediatric primary care. In addition to identifying appropriate descriptive …
encountered in pediatric primary care. In addition to identifying appropriate descriptive …
Molecular findings among patients referred for clinical whole-exome sequencing
Importance Clinical whole-exome sequencing is increasingly used for diagnostic evaluation
of patients with suspected genetic disorders. Objective To perform clinical whole-exome …
of patients with suspected genetic disorders. Objective To perform clinical whole-exome …
Clinical whole-exome sequencing for the diagnosis of mendelian disorders
Background Whole-exome sequencing is a diagnostic approach for the identification of
molecular defects in patients with suspected genetic disorders. Methods We developed …
molecular defects in patients with suspected genetic disorders. Methods We developed …
[HTML][HTML] A clinical primer on intellectual disability
DR Patel, MD Cabral, A Ho, J Merrick - Translational pediatrics, 2020 - ncbi.nlm.nih.gov
Abstract Between 1% and 3% of persons in general population are estimated to have some
degree of intellectual disability. A diagnosis of intellectual disability is based on clinical …
degree of intellectual disability. A diagnosis of intellectual disability is based on clinical …
Comprehensive evaluation of the child with intellectual disability or global developmental delays
Global developmental delay and intellectual disability are relatively common pediatric
conditions. This report describes the recommended clinical genetics diagnostic approach …
conditions. This report describes the recommended clinical genetics diagnostic approach …
Clinical exome sequencing: results from 2819 samples reflecting 1000 families
D Trujillano, AM Bertoli-Avella… - European Journal of …, 2017 - nature.com
We report our results of 1000 diagnostic WES cases based on 2819 sequenced samples
from 54 countries with a wide phenotypic spectrum. Clinical information given by the …
from 54 countries with a wide phenotypic spectrum. Clinical information given by the …
[HTML][HTML] Developmental delay: identification and management at primary care level
YY Choo, P Agarwal, CH How… - Singapore medical …, 2019 - ncbi.nlm.nih.gov
Developmental delays are common in childhood, occurring in 10%–15% of preschool
children. Global developmental delays are less common, occurring in 1%–3% of preschool …
children. Global developmental delays are less common, occurring in 1%–3% of preschool …
Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
DJ Stavropoulos, D Merico, R Jobling, S Bowdin… - NPJ genomic …, 2016 - nature.com
The standard of care for first-tier clinical investigation of the aetiology of congenital
malformations and neurodevelopmental disorders is chromosome microarray analysis …
malformations and neurodevelopmental disorders is chromosome microarray analysis …
Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies
DT Miller, MP Adam, S Aradhya, LG Biesecker… - The American Journal of …, 2010 - cell.com
Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with
unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders …
unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders …